Rapport Therapeutics, Inc. - RAPP
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Third Rock Ventures V, L.P. | 13.1% | 6,280,525 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Third Rock Ventures GP V, L.P. | 13.1% | 6,280,525 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | TRV GP V, LLC | 13.1% | 6,280,525 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Third Rock Ventures VI, L.P. | 2.0% | 969,218 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Third Rock Ventures GP VI, L.P. | 2.0% | 969,218 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | TRV GP VI, LLC | 2.0% | 969,218 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Cormorant Asset Management, LP | 5.56% | 2,657,521 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Bihua Chen | 5.56% | 2,657,521 | View |
| Aug 12, 2026 | SCHEDULE 13G/A | Capital International Investors | 6.1% | 2,921,958 | View |
| May 15, 2026 | SCHEDULE 13G/A | Cormorant Asset Management, LP | 6.19% | 2,957,521 | View |
| May 15, 2026 | SCHEDULE 13G/A | Bihua Chen | 6.19% | 2,957,521 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.